Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Linear Diagnostics
Birmingham, England, United Kingdom
- Ownership
- Private
- Development stage
- Other
01
Overview
Linear Diagnostics has developed a rapid point-of-care diagnostic platform using linear dichroism and EXPAR technology that can deliver results in under 15 minutes, especially focused on sexually transmitted infections. Clinical performance results are not detailed in public sources, but the technology reportedly allows simultaneous multiplex detection with high accuracy[1][3].
- Therapeutic areas
- Infectious Diseases
- Modalities
- DeviceDiagnostic assay
- Industry
- Molecular Diagnostics
Beyond the preview
Go deeper on Linear Diagnostics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Linear Diagnostics.